Prospectus

Relay Therapeutics, Inc. Filed 2022-09-12 Acc 0001193125-22-242425

Documents 1

2022-09-15 4 President and CEO sold 42,000 shares at an average $24.24 ($1,018,080)
2022-09-15 8-K Material agreement · Other events
2022-09-13 424B5 Prospectus
2022-09-12 424B5 Prospectus
2022-09-12 8-K Regulation FD disclosure · Other events
2022-09-08 4 Chief Financial Officer sold 26,257 shares at $30.00 ($787,710)
2021-10-13 424B5 Prospectus

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading d298340d424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…